Klow (80 mg (50/10/10/10))
KLOW Blend is a four-peptide research complex combining GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and anti-inflammatory tripeptide KPV (10 mg), individually assayed by multi-peak RP-HPLC prior to co-lyophilization.
Scientific Profile & Research Key Points: Klow
KLOW Blend is a four-peptide research complex combining GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and anti-inflammatory tripeptide KPV (10 mg), individually assayed by multi-peak RP-HPLC prior to co-lyophilization.
Active Batch Release Specifications (Lot SL-2026-137)
Analytical release verification for current Klow (80 mg (50/10/10/10)) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-137 | 2026-10-28 | Gradient RP-HPLC (Multi-Peak Resolution) + ESI-MS | ≥99.0% (Resolved Constituent Peaks) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water (3.0–4.0 mL); gently swirl until clear blue
Temperature & Stability
Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C for up to 28 days.
Klow — Technical Questions & Answers
How are the individual constituents of Klow verified in a single vial?
Because co-lyophilized blends contain multiple sequences with distinct retention times, Lot SL-2026-137 is evaluated via gradient RP-HPLC to resolve each constituent peak independently, paired with ESI-MS mass confirmation (403.93 / 1419.53 / 4963.50 / 342.43 g/mol).
How do you calculate working stock aliquots for a multi-component blend like Klow?
Calculate each active constituent separately based on its labeled mass ratio (80 mg (50/10/10/10)) divided by total diluent volume added. For example, adding 2.0 mL of sterile diluent yields proportional mg/mL concentrations for every component simultaneously.
What primary pathways are investigated using Klow?
Investigators study Klow in ECM remodeling, angiogenesis, G-actin motility & NF-κB anti-inflammatory signaling models. Primary published literature context: Multi-constituent peptide formulation combining GHK-Cu, BPC-157, TB-500, and α-MSH(11-13) tripeptide KPV. All lots are supplied strictly for in-vitro laboratory experimentation.
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
GHK-Cu: Biochemistry of the Gly-His-Lys Copper Complex in Gene Expression and Tissue Remodeling
A biochemical review of the human tripeptide copper complex GHK-Cu. Epigenetic gene resetting, metalloproteinase modulation, collagen/elastin synthesis, and analytical HPLC verification.
Glutathione: The γ-Glutamyl Isopeptide Bond, Redox Potentials, and GSSG Dimerization
A molecular analysis of reduced Glutathione (GSH) vs oxidized Glutathione Disulfide (GSSG). Why the unusual gamma-peptide bond protects against intracellular peptidases.
KLOW Blend: Multi-Peptide Co-Lyophilization and HPLC Chromatography of Complex Mixtures
Analyzing complex multi-compound formulations (GHK-Cu, BPC-157, TB-500, KPV). How co-lyophilization affects individual peptide stability, retention peaks, and analytical verification.
Related Longevity & Cellular Biology Compounds
View category →